Related Experiment Video
Updated: Apr 18, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism
Kang I Ko1, Leila S Coimbra2, Chen Tian1
1Department of Periodontics, University of Pennsylvania, 240 S 40th St, Levy 122 Philadelphia, PA19104, USA.
Aims/Hypothesis:
Diabetes interferes with bone formation and impairs fracture healing, an important complication in humans and animal models. The aim of this study was to examine the impact of diabetes on mesenchymal stem cells (MSCs) during fracture repair.
Methods:
Fracture of the long bones was induced in a streptozotocin-induced type 1 diabetic mouse model with or without insulin or a specific TNFα inhibitor, pegsunercept. MSCs were detected with cluster designation-271 (also known as p75 neurotrophin receptor) or stem cell antigen-1 (Sca-1) antibodies in areas of new endochondral bone formation in the calluses. MSC apoptosis was measured by TUNEL assay and proliferation was measured by Ki67 antibody. In vitro apoptosis and proliferation were examined in C3H10T1/2 and human-bone-marrow-derived MSCs following transfection with FOXO1 small interfering (si)RNA.
Results:
Diabetes significantly increased TNFα levels and reduced MSC numbers in new bone area. MSC numbers were restored to normal levels with insulin or pegsunercept treatment. Inhibition of TNFα significantly reduced MSC loss by increasing MSC proliferation and decreasing MSC apoptosis in diabetic animals, but had no effect on MSCs in normoglycaemic animals. In vitro experiments established that TNFα alone was sufficient to induce apoptosis and inhibit proliferation of MSCs. Furthermore, silencing forkhead box protein O1 (FOXO1) prevented TNFα-induced MSC apoptosis and reduced proliferation by regulating apoptotic and cell cycle genes.
Conclusions/Interpretation:
Diabetes-enhanced TNFα significantly reduced MSC numbers in new bone areas during fracture healing. Mechanistically, diabetes-enhanced TNFα reduced MSC proliferation and increased MSC apoptosis. Reducing the activity of TNFα in vivo may help to preserve endogenous MSCs and maximise regenerative potential in diabetic patients.
Insights
Diabetes impairs fracture healing by increasing TNFα, which reduces mesenchymal stem cell (MSC) numbers. Inhibiting TNFα preserves MSCs and enhances healing potential in diabetic patients.
Area of Science:
- Biomedical Science
- Regenerative Medicine
- Orthopedics
Background:
- Diabetes mellitus is a metabolic disorder that negatively impacts bone health and fracture repair.
- Mesenchymal stem cells (MSCs) play a critical role in the complex process of fracture healing.
- Elevated levels of tumor necrosis factor-alpha (TNFα) are observed in diabetic complications.
Purpose of the Study:
- To investigate the effect of diabetes on MSCs during long bone fracture repair.
- To elucidate the role of TNFα in diabetes-induced MSC dysfunction.
- To assess the therapeutic potential of TNFα inhibition in diabetic fracture healing.
Main Methods:
- A type 1 diabetes mouse model was established using streptozotocin.
- Fractures were induced, and animals were treated with insulin or a TNFα inhibitor (pegsunercept).
- MSCs were identified, and their proliferation and apoptosis were quantified using specific markers and assays (Ki67, TUNEL). In vitro studies utilized C3H10T1/2 and human bone marrow-derived MSCs with FOXO1 siRNA.
Main Results:
- Diabetes significantly increased TNFα levels and decreased MSC numbers in fracture calluses.
- Insulin or pegsunercept treatment restored MSC numbers to normal levels.
- TNFα inhibition in diabetic mice increased MSC proliferation and decreased apoptosis, improving fracture healing. In vitro, TNFα induced MSC apoptosis and inhibited proliferation, effects mitigated by silencing FOXO1.
Conclusions:
- Diabetes-induced elevation of TNFα is a key factor in reducing MSC numbers during fracture healing.
- TNFα negatively impacts MSCs by promoting apoptosis and reducing proliferation, partly through FOXO1 regulation.
- Targeting TNFα activity presents a promising strategy to preserve MSCs and enhance fracture healing in diabetic individuals.
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Mesenchymal Stem Cells
Diabetic Foot Ulcer
Psychoneuroimmunology: Diabetes and Cancer
Type I Diabetes II: Pathophysiology
Stem Cell Niche

